Search - tctmd.com

Displaying 41 - 60 of 245

Sort: Relevancy | Date

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

Todd Neale

January 21, 2024

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

Advertisement

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

AHA Celebrates a Century by Looking Back, and Forward

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

TCTMD’s Top 10 Most Popular Stories for May 2024

Statins Effective For Primary Prevention in Old and Very Old

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Main Results From The Step-hfpef Dm Trial

Semaglutide Winning Streak Continues in CKD With FLOW

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

January 2024 Dispatch for the CV Team

AHA Selects 2023’s Leading Cardiovascular Research

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content